Emirena Garrafa Selected Research

Emirena Garrafa Research Topics

Disease

4	Neoplasms (Cancer) 06/2022 - 06/2002
4	COVID-19 01/2021 - 01/2020
4	Hypoxia (Hypoxemia) 11/2014 - 03/2009
3	Infections 07/2007 - 07/2002
2	Rheumatoid Arthritis 09/2021 - 01/2021
2	Inflammation (Inflammations) 01/2021 - 01/2016
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 07/2020 - 01/2020
2	Abdominal Aortic Aneurysm 01/2018 - 01/2016
2	Necrosis 03/2011 - 01/2003
2	Virus Diseases (Viral Diseases) 07/2007 - 08/2002
1	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2022
1	Rupture 06/2022
1	Systemic Scleroderma (Systemic Sclerosis) 06/2022
1	digital ulcers 06/2022
1	Gastric Antral Vascular Ectasia (Watermelon Stomach) 06/2022
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Heart Failure 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Disease Progression 01/2021
1	Pneumonia (Pneumonitis) 07/2020
1	Lymphopenia (Lymphocytopenia) 07/2020
1	Respiratory Insufficiency (Respiratory Failure) 07/2020
1	Dementia (Dementias) 12/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2018
1	Alzheimer Disease (Alzheimer's Disease) 12/2018
1	Movement Disorders (Movement Disorder) 11/2018
1	Thrombosis (Thrombus) 01/2016
1	Aneurysm (Aneurysms) 01/2016
1	Melanoma (Melanoma, Malignant) 04/2014
1	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2013
1	Multiple Sclerosis 10/2012
1	Carcinogenesis 03/2009
1	Hepatocellular Carcinoma (Hepatoma) 10/2008

Drug/Important Bio-Agent (IBA)

7	AntibodiesIBA 06/2022 - 10/2008
5	CytokinesIBA 01/2021 - 07/2002
4	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 09/2021 - 03/2011
4	C-Reactive ProteinIBA 01/2021 - 01/2016
4	Vascular Endothelial Growth Factor CIBA 01/2016 - 03/2009
4	Endothelin-1 (Endothelin 1)IBA 11/2014 - 03/2009
3	Interleukin-8 (Interleukin 8)IBA 01/2021 - 08/2002
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 03/2011
3	ChemokinesIBA 01/2021 - 08/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2014 - 03/2009
2	Abatacept (Orencia)FDA Link 09/2021 - 01/2021
2	Phospholipids (Phosphatides)FDA LinkGeneric 07/2020 - 01/2020
2	EpitopesIBA 07/2020 - 01/2020
2	Monoclonal AntibodiesIBA 07/2020 - 10/2012
2	Fibrinogen (Factor I)FDA Link 07/2020 - 01/2016
2	Small Interfering RNA (siRNA)IBA 04/2014 - 03/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2014 - 10/2012
2	Neutralizing AntibodiesIBA 10/2012 - 07/2007
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2011 - 08/2002
2	InterferonsIBA 03/2011 - 01/2003
1	AutoantibodiesIBA 06/2022
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 06/2022
1	RNA Polymerase IIIIBA 06/2022
1	SiliconesIBA 06/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Interferon Type IIBA 01/2021
1	Cystatin CIBA 01/2021
1	Angiotensin IIIBA 01/2021
1	Anti-Idiotypic AntibodiesIBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	tocilizumab (atlizumab)FDA Link 07/2020
1	Ferritins (Ferritin)IBA 07/2020
1	Amyloid (Amyloid Fibrils)IBA 12/2018
1	tau Proteins (tau Protein)IBA 12/2018
1	IronIBA 11/2018
1	Lipoprotein(a)IBA 01/2016
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 11/2014
1	Conditioned Culture MediaIBA 04/2014
1	Endothelins (Endothelin)IBA 04/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2013
1	matrigelIBA 10/2012
1	BQ 788IBA 10/2012
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 10/2012
1	Natalizumab (Tysabri)FDA Link 10/2012
1	Chemokine CCL5IBA 03/2011
1	Chemotactic FactorsIBA 10/2008
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 10/2008
1	AntigensIBA 07/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2003
1	Biological ProductsIBA 08/2002
1	Antiviral Agents (Antivirals)IBA 07/2002
1	EnzymesIBA 06/2002

Therapy/Procedure

1	Breast Implants (Breast Implant) 06/2022
1	Patient Readmission 01/2021
1	Intravenous Administration 07/2020
1	Stem Cell Transplantation 02/2013